Outset Medical, Inc.

For the period ended Jun 30, 2025. Filed Aug 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 7, 2025

OM$4.23+3.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Operations

(in thousands, except per share amounts)

Three Months Ended · Six Months Ended
	June 30,		June 30,
	2025	2024	2025	2024
Revenue:
Product revenue	$23,082	$19,238	$44,376	$39,666
Service and other revenue	8,337	8,150	16,795	15,890
Total revenue	31,419	27,388	61,171	55,556
Cost of revenue:
Cost of product revenue	11,791	10,567	22,793	23,148
Cost of service and other revenue	7,761	7,039	15,445	14,411
Total cost of revenue	19,552	17,606	38,238	37,559
Gross profit	11,867	9,782	22,933	17,997
Operating expenses:
Research and development	5,289	9,734	10,804	22,369
Sales and marketing	14,280	18,128	27,932	39,176
General and administrative	9,163	12,684	17,461	24,128
Total operating expenses	28,732	40,546	56,197	85,673
Loss from operations	(16,865)	(30,764)	(33,264)	(67,676)
Interest income and other income, net	1,903	2,471	3,879	5,569
Interest expense	(3,475)	(6,010)	(7,035)	(11,978)
Loss on extinguishment of term loan	—	—	(7,685)	—
Loss before provision for income taxes	(18,437)	(34,303)	(44,105)	(74,085)
Provision for income taxes	104	151	219	313
Net loss	$(18,541)	$(34,454)	$(44,324)	$(74,398)
Net loss per share, basic and diluted	$(1.04)	$(9.96)	$(3.57)	$(21.72)
Shares used in computing net loss per share, basic and diluted	17,743	3,458	12,420	3,426

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.